BROCA sequencing of NCI10066 patient NGS-10066-002 normal tissue

SRX22428523 002-N BROCA sequencing of NCI10066 patient NGS-10066-002 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460046 NGS-10066-002-N 002-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428524 003-G BROCA sequencing of NCI10066 patient NGS-10066-003 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460047 NGS-10066-003-G 003-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428525 008-G BROCA sequencing of NCI10066 patient NGS-10066-008 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460048 NGS-10066-008-G 008-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428526 008-T BROCA sequencing of NCI10066 patient NGS-10066-008 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460049 NGS-10066-008-T 008-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428527 009-G BROCA sequencing of NCI10066 patient NGS-10066-009 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460050 NGS-10066-009-G 009-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428528 009-T BROCA sequencing of NCI10066 patient NGS-10066-009 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460051 NGS-10066-009-T 009-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428529 010-G BROCA sequencing of NCI10066 patient NGS-10066-010 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460052 NGS-10066-010-G 010-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428530 010-T BROCA sequencing of NCI10066 patient NGS-10066-010 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460053 NGS-10066-010-T 010-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428531 011-N BROCA sequencing of NCI10066 patient NGS-10066-011 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460054 NGS-10066-011-N 011-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428532 011-T BROCA sequencing of NCI10066 patient NGS-10066-011 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460055 NGS-10066-011-T 011-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428533 013-N BROCA sequencing of NCI10066 patient NGS-10066-013 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460056 NGS-10066-013-N 013-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428534 013-T BROCA sequencing of NCI10066 patient NGS-10066-013 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460057 NGS-10066-013-T 013-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428535 003-T BROCA sequencing of NCI10066 patient NGS-10066-003 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460058 NGS-10066-003-T 003-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428536 014-N BROCA sequencing of NCI10066 patient NGS-10066-014 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460059 NGS-10066-014-N 014-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428537 014-T BROCA sequencing of NCI10066 patient NGS-10066-014 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460060 NGS-10066-014-T 014-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428538 015-N BROCA sequencing of NCI10066 patient NGS-10066-015 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460061 NGS-10066-015-N 015-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428539 015-T BROCA sequencing of NCI10066 patient NGS-10066-015 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460062 NGS-10066-015-T 015-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428540 016-T BROCA sequencing of NCI10066 patient NGS-10066-016 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460063 NGS-10066-016-T 016-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428541 017-N BROCA sequencing of NCI10066 patient NGS-10066-017 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460064 NGS-10066-017-N 017-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428542 017-T BROCA sequencing of NCI10066 patient NGS-10066-017 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460065 NGS-10066-017-T 017-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428543 019-T BROCA sequencing of NCI10066 patient NGS-10066-019 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460066 NGS-10066-019-T 019-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428544 020-G BROCA sequencing of NCI10066 patient NGS-10066-020 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460067 NGS-10066-020-G 020-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428545 020-T BROCA sequencing of NCI10066 patient NGS-10066-020 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460068 NGS-10066-020-T 020-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428546 004-G BROCA sequencing of NCI10066 patient NGS-10066-004 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460069 NGS-10066-004-G 004-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428547 022-N BROCA sequencing of NCI10066 patient NGS-10066-022 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460070 NGS-10066-022-N 022-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428548 022-T BROCA sequencing of NCI10066 patient NGS-10066-022 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460071 NGS-10066-022-T 022-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428549 024-T BROCA sequencing of NCI10066 patient NGS-10066-024 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460072 NGS-10066-024-T 024-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428550 028-G BROCA sequencing of NCI10066 patient NGS-10066-028 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460073 NGS-10066-028-G 028-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428551 028-T BROCA sequencing of NCI10066 patient NGS-10066-028 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460074 NGS-10066-028-T 028-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428552 029-N BROCA sequencing of NCI10066 patient NGS-10066-029 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460075 NGS-10066-029-N 029-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428553 029-T BROCA sequencing of NCI10066 patient NGS-10066-029 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460076 NGS-10066-029-T 029-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428554 030-G BROCA sequencing of NCI10066 patient NGS-10066-030 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460077 NGS-10066-030-G 030-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428555 031-G BROCA sequencing of NCI10066 patient NGS-10066-031 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460078 NGS-10066-031-G 031-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428556 031-T BROCA sequencing of NCI10066 patient NGS-10066-031 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460079 NGS-10066-031-T 031-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428557 004-T BROCA sequencing of NCI10066 patient NGS-10066-004 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460080 NGS-10066-004-T 004-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428558 032-T BROCA sequencing of NCI10066 patient NGS-10066-032 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460081 NGS-10066-032-T 032-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428559 035-N BROCA sequencing of NCI10066 patient NGS-10066-035 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460082 NGS-10066-035-N 035-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428560 035-T BROCA sequencing of NCI10066 patient NGS-10066-035 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460083 NGS-10066-035-T 035-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428561 036-N BROCA sequencing of NCI10066 patient NGS-10066-036 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460084 NGS-10066-036-N 036-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428562 036-T BROCA sequencing of NCI10066 patient NGS-10066-036 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460085 NGS-10066-036-T 036-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428563 037-G BROCA sequencing of NCI10066 patient NGS-10066-037 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460086 NGS-10066-037-G 037-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428564 037-T BROCA sequencing of NCI10066 patient NGS-10066-037 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460087 NGS-10066-037-T 037-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428565 038-N BROCA sequencing of NCI10066 patient NGS-10066-038 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460088 NGS-10066-038-N 038-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428566 038-T BROCA sequencing of NCI10066 patient NGS-10066-038 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460092 NGS-10066-038-T 038-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428567 039-N BROCA sequencing of NCI10066 patient NGS-10066-039 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460089 NGS-10066-039-N 039-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428568 005-T BROCA sequencing of NCI10066 patient NGS-10066-005 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460090 NGS-10066-005-T 005-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428569 039-T BROCA sequencing of NCI10066 patient NGS-10066-039 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460091 NGS-10066-039-T 039-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428570 040-N BROCA sequencing of NCI10066 patient NGS-10066-040 normal tissue SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460093 NGS-10066-040-N 040-N Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428571 040-T BROCA sequencing of NCI10066 patient NGS-10066-040 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460094 NGS-10066-040-T 040-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428572 005-G BROCA sequencing of NCI10066 patient NGS-10066-005 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460095 NGS-10066-005-G 005-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428573 006-G BROCA sequencing of NCI10066 patient NGS-10066-006 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460096 NGS-10066-006-G 006-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428574 006-T BROCA sequencing of NCI10066 patient NGS-10066-006 gastroesophageal cancer SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460097 NGS-10066-006-T 006-T Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000 SRX22428575 007-G BROCA sequencing of NCI10066 patient NGS-10066-007 blood SRP470891 bp0 BROCA-GO is a targeted next generation sequencing assay which identifies all classes of mutations in gynecologic cancer susceptibility genes, genes associated with HRR, and other genes frequently altered in gynecologic cancers. SRS19460098 NGS-10066-007-G 007-G Targeted-Capture GENOMIC Hybrid Selection Illumina NovaSeq 6000